Compare NEPH & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEPH | BAFN |
|---|---|---|
| Founded | 1997 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.0M | 26.6M |
| IPO Year | 2004 | 2021 |
| Metric | NEPH | BAFN |
|---|---|---|
| Price | $3.49 | $6.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 20.5K | ★ 59.1K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.00% |
| EPS Growth | ★ 1000.00 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $18,789,000.00 | N/A |
| Revenue This Year | $11.24 | N/A |
| Revenue Next Year | $11.58 | N/A |
| P/E Ratio | $28.41 | ★ N/A |
| Revenue Growth | ★ 32.67 | N/A |
| 52 Week Low | $2.05 | $4.80 |
| 52 Week High | $6.42 | $16.35 |
| Indicator | NEPH | BAFN |
|---|---|---|
| Relative Strength Index (RSI) | 60.66 | 44.73 |
| Support Level | $2.77 | $5.73 |
| Resistance Level | $4.92 | $7.08 |
| Average True Range (ATR) | 0.29 | 0.83 |
| MACD | 0.05 | -0.16 |
| Stochastic Oscillator | 63.84 | 37.02 |
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.
BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.